TORPIDO2- Targeted Oxygen for Resuscitation of Preterm Infants effects on Developmental Outcomes 2

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1089056

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Either too much or too little oxygen (O2) causes prolonged harm and death, even if this imbalance is for a few minutes, as at birth. Nowhere is this balance more critical than in the care of the extremely preterm infant (below 28 weeks gestation) with lung immaturity (requiring O2) and antioxidant deficiency. The Torpido 2 study will randomize 1350 infants below 28 weeks gestation to determine long-term neurodevelopmental outcomes and survival after resuscitation with either 21% O2 (room air) or

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2019

Funding Scheme: Project Grants

Funding Amount: $2,293,459.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

developmental outcomes | oxygen therapy | premature infant | randomised controlled trial (RCT) | resuscitation

Related Links